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Abstract 
Background: Congenital infections are the most important threat to human fetal health caused by bacterial, viral, 
and fungal agents. In this study, PCR diagnostic method has been used on umbilical cord samples to diagnose 
bacterial agents such as Mycoplasmas, especially Mycoplasma genitalium. Materials and Methods: This study was 
performed on 100 cord blood samples from cesarean section patients. Limit of detection (LOD) and specificity tests 
of both PCR was performed. DNA samples were extracted by the DNG plus method and amplified by the PCR 
technique. The optimized PCR product of 715 bp for Mycoplasma spp. and 427 bp for M. genitalium was amplified 
and observed on 1.5% gel electrophoresis. DNA specificity testing of seven other organisms revealed a 100% 
specificity of these primers. The detection limit was set at 100 copy / reaction for Mycoplasma.spp and 1000 copy / 
reaction for M. genitalium.  Results: Of the 100 samples examined, 5 samples were positive for Mycoplasma spp, 
and no positive cases were observed for M. genitalium. Maternal infections can have important consequences on 
the fetus. Conclusion: Molecular methods such as PCR could be used for rapid identification of important factors in 
congenital infections, such as mycoplasma, and provide a good prognosis. 
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Congenital infections are the most important 
threat to human fetal health caused by bacterial, viral, 
and fungal factors. However, the majority of 
congenital infections are caused by viral factors such 
as the cytomegalovirus, varicella-zoster virus, herpes 
simplex virus, rubella virus, etc., which may be 
present in the cord blood. Genital or respiratory 
infections caused by bacterial agents such as 
Mycoplasmas are an important part of medical 
reports.[1-3]. Genital Mycoplasmas are one of the 
major contributing factors of vaginitis, cervicitis, and 
pelvic inflammatory disease (PID) in women referred 
to obstetric clinics. These organisms attach to the 
mucosal surfaces of the genital tract. Due to the high 
potency of colonization in endocervixes, they are 
likely to cause adverse effects for the mother and her 
baby [4, 5]M. genitalium was first isolated from the 
urinary tract of men with non-gonococcal urethritis 
(NGU). This Mycoplasma is very similar to M. 
pneumonia and causes PID, Urethritis, endometritis, 
and cervicitis[6, 7]. Among the 16 species isolated 
from human, only M. pneumonia has been identified 
as a genuine human pathogen [8, 9].This bacteria is an 
important and common cause of acute respiratory 
infections[10, 11] and has been isolated from human 
urogenital tracts [12].In the reproductive system, M. 
hominis and also M. genitalium can sometimes 
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exacerbate bacterial vaginosis or nonspecific (non-
gonococcal) urethritis or even miscarriage [13]. 
Frequent isolation of U. urealyticum from men with 
non-gonococcal urethritis revealed that it causes 
other infections in addition to genital infections[14], 
such as endocarditis and osteomyelitis [15]and even 
chronic lung infections in infants, bacteremia, and 
death[16]. However, due to the problems 
encountered in the cultivation and inoculation of 
these bacteria in the laboratories, the role of these 
organisms in causing human infection, and in 
particular the adverse effects have been 
underestimated in our country. Mycoplasmas cause 
various diseases in the genitourinary and respiratory 
tracts and cause abnormal reproductive and neonatal 
mortality [17]. There are various types of 
Mycoplasmas in the genitourinary tract that act as 
opportunistic organisms[18].  
Genital Mycoplasmas, especially M. hominins
and U. urealyticum, are natural residents of the 
genitourinary tract of men and women who have 
sexual activity. These bacteria are more common in 
women than men and are transmitted by sexual 
intercourse or from mother to baby at birth. 
According to research by Kacerovsky et al. in 2014 
on cord blood samples of pregnant women studied, 
microorganisms such as Ureaplasma spp. And M. 
hominis was about 9%. No significant relationship 
was observed between the microbial load of the 
amniotic fluid and the cord blood because, under 
normal conditions, the amniotic fluid should be 
sterile[19]. Stellrecht used PCR instead of culture in 
his study, and the results showed that PCR could be a 
suitable method for the detection of M. genitalium
and other genital Mycoplasmas in clinical samples. A 
study by Luki et al., using PCR on samples from 
pregnant women, showed 3.6% of M. 
genitalium[20].In a study on the infection caused by 
genital Mycoplasma in 174 women with bacterial 
vaginosis is performed by Vatani and colleagues, the 
predominance of molecular methods such as PCR 
(77.6%) compared to culture (about 40.8%) was 
proven[21].  
          Of the Mycoplasma species, M.penetrans- 
M.pirum- M.primatum-M.spermatophilu and 
M.amphoriforme have the least threat in 
pregnancy[22]. In recent years, the evaluation of 
different species of Mycoplasma in the reproductive 
system such as M.fermentans, M.Penetrans, and 
M.genitalium has been developed by molecular 
methods such as PCR[23]. The purpose of this study 
was to find a suitable diagnostic method for the 
diagnosis of Mycoplasma spp. as well as  M. 
genitalium in congenital cord blood infections, 
because the failure in timely diagnoses may increase 
the risk of delayed treatment or overuse of broad-
spectrum antibiotics.  
Methods 
Species used in this study were M. pneumoniae 
(NCTC 10119), M. arginini, M. hyorhinis, M. hominis, 
M. orale, Acholeplasma laidlawii., Mycobacterium 
tuberculosis, Pseudomonas aeruginosa, 
Staphylococcus aureus, Salmonella typhimurium
provided from Razi Institute and Pasteur Institute of 
Iran. 
Collection of the studied samples. In this study, 
100 cord blood samples of cesarean patients were 
collected from Mustafa Khomeini Hospital. DNA 
extraction from cord blood samples was performed by 
the DNG-PLUS method[24]. 
PCR test. The required compounds for PCR 
were prepared in 25 µL volume by the following 
order: Five nanogram (ng) template DNA (in 5 µL) , 
0.2 µM of each primers , 1.5 mM Mgcl2 (sinaclon) , 
0.2 mM dNTP Mixture, and 1.5 unit of Taq DNA 
Polymerase (sinaclon),2.5 µL 10x PCR buffer 
(sinaclone) and 14µl of deionized sterile double 
distilled water used for reaching to the target volume. 
The thermal program used and optimized was: 
heating at 93 ° C for 20 seconds, 60 ° C for 20 
seconds, and finally 72 ° C for 30 seconds, which 
was performed for 40 cycles of amplification. The 
PCR product with the desired size (715 bp), along 
with the size marker and positive and negative 
control, was analyzed on 1.5% agarose gel using 
SYBR safe (Sinaclon) in the gel documentation 
system (Major-science). 
The primers encode a 715 bp product and their 
target gene is fixed, stable, or shared sequences 
(consensus sequence) 16SrRNA fragment of 
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Mycoplasma[25]. 
Table1. All primers are used in this study. 
Bacteria Primers Sequence 
Tm 
(oC) 










GPO-1    
MGSO 





Limit of Detection (LOD) and specificity. To 
determine the LOD of the primers used in this study, 
different dilutions were prepared from M. genitalium
suspension with specific CFU, their DNA was 
extracted and finally, the PCR test was performed on 
the samples with the specified number. Specificity 
testing using DNA from several organisms such as M. 
tuberculosis,  P. aeruginosa, S. typhimurium, S. 
aureus, Hepatitis B virus, as well as human and mouse 
DNA for Mycoplasma spp. and organisms such as M. 
pneumoniae, A. laidlawii, M. orale, M. arginini, M. 
hyorhinis, M. hominis, and Trichomonas vaginalis
were performed for M. genitalium. Optimized PCR 
test was performed with positive and negative 
controls. 
Results 
Using GPO-3, MGSO, and, Mycoplasmas DNA 
such as M. pneumoniae, M. genitalium, M. hyorhinis, 
M. orale, PCR was optimized for Mycoplasma spp
detection. This PCR test produced a 715bp product 
with the DNA of all tested Mycoplasmas (Figure 
1a).By using FMGe427 and RMGe427 primers and M. 
genitalium DNA, the PCR detection test for this 
bacteria was optimized and 427 bp product was 
amplified (Figure 1b).In both cases, the 16SrRNA was 
considered as target gene[28]. 
Figure 1: Optimized PCR tests for Mycoplasma spp and M. genitalium
Figure 1a: Optimized PCR Test for Mycoplasma spp detection Column 
M: Size of DNA marker (Middle Range DNA Ladder Thermo 
scientific), C +: Positive control (M. genitalium), C-: Negative control. 
Figure 1b: Optimized PCR Test for M. genitalium detection Column M: 
Size of DNA marker (1Kb Ladder bioflux), C +: Positive control (M. 
genitalium), C-: Negative control 
Evaluation of test detection limit was performed 
by dilution of Mycoplasma culture with specific 
colonies. results showed that the sensitivity of the PCR 
test for Mycoplasma spp was 100 copies (Figure 2a) 
and the PCR detection sensitivity of M. genitalium 
was 1000 copies in one test (Figure 2b) 
Monzavi et al.                                          Evaluation of PCR for the Identification of Mycoplasma spp. and Mycoplasma… 
Vol 5, No 2,  Spring  2019 
32 
Figure 2: Limit of detection test of PCR for both Mycoplasma spp and 
M. genitalium Figure 2a: Optimized PCR detection test for M. 
genitalium: Column M: Size marker, (100 bp DNA Ladder 
Thermoscientific) C+: Positive control, Column1: 106 CFU, Column 2: 
105 CFU, Column 3: 104 CFU, Column 4: 103 CFU, Column 5: 100 
CFU, Column 6: 10 CFU, Column 7: 1 CFU, C-: Negative control
Figure 2b: Optimized PCR detection test for Mycoplasma spp: Column 
M: Size marker, (100 bp DNA Ladder Thermoscientific) C+: Positive 
control, Column1: 108 CFU, Column 2: 107 CFU, Column 3: 106 CFU, 
Column 4: 105 CFU, Column 5: 104 CFU, Column 6: 103 CFU, Column 
7: 100 CFU, C-: Negative control 
           By performing specificity tests for PCR 
detection of Mycoplasma spp revealed that the primers 
used have made no unwanted product with the DNA of 
non-Mycoplasma bacteria such as M. tuberculosis, P. 
aeruginosa, S. typhimurium, S. aureus, viruses such as
B hepatitis, and also human and rat DNA (Figure 3a). 
         M. genitalium specificity test with primers used, 
no unwanted products with DNA of M. pneumoniae,A. 
laidlawii,M. orale, M. arginini, M. hyorhinis, M. 
hominis and T. vaginalis (Figure 3b). 
Figure 3: Specificity of PCR tests for the detection of Mycoplasma spp
and M. genitalium Figure 3a. Specificity of PCR test for Mycoplasma 
spp detection. Column M: Size marker size (Middle Range DNA 
Ladder Thermoscientific), C+: Positive control, Column 1: Human 
DNA, Column 2: Rat DNA, Column 3: M. tuberculosis, Column 4: P. 
aeruginosa, Column 5:  S. aureus, Column 6: S. typhimurium, Column 
7: B and C Hepatitis virus, C-: Negative control Figure 3b. Specificity 
of PCR test for M. genitalium detection. Column M: Size marker (1Kb 
DNA Ladder (bioflux)), C+: Positive Control, Column 1: M. 
pneumoniae, Column 2: A.laidlawii, Column 3: M. tuberculosis,
Column 4: M. orale, Column 5:  M. hyorhinis, Column 6: M. hominis,
Column 7: T. vaginalis, C-: Negative control 
           Mycoplasma infection in 100 cord blood 
samples was    searched by PCR.  5 samples (5%) were 
positive for Mycoplasma spp but none of them were 
positive for M. genitalium. 
Discussion 
          This study attempts to investigate the diagnostic 
potential of PCR testing for Mycoplasma infections in 
neonatal cord blood. Evaluation of cord blood seems 
to be helpful in the diagnosis of neonatal harms, 
including sepsis [29, 30]. According to Leena and 
colleagues research, sensitive and accurate diagnosis 
of sepsis in newborns is very difficult, and sepsis is the 
result of an intrauterine infection [31]. Failure in 
timely diagnose may increase the risk of delayed 
treatment or overuse of broad-spectrum antibiotics 
[32]Methods of diagnosis of sepsis include blood 
culture but there are some disadvantages such as 
timing, sensitivity, maternal antibiotic use, low sample 
size, and low pathogen concentration in the sample[33, 
34]. Other laboratory tests, such as white blood cell 
count and CRP, have low specificity [35, 36]. Due to 
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the lack of reliable diagnostic methods in the NICU, 
long-term use of antibiotics can lead to dangerous 
consequences such as necrosis, enterocolitis, antibiotic 
resistance, fungal infections and hearing loss [37, 38]. 
Evaluation of cord blood reflects intrauterine 
inflammation, where premature infants develop sepsis. 
Rapid detection of genital Mycoplasmas, 
especially in pregnant women and preterm infants, is 
essential because these organisms can lead to 
spontaneous miscarriage, postpartum fever, 
chorioamnionitis, preterm delivery, and premature 
birth. Premature infants with low birth weight also 
may develop respiratory distress syndrome, 
pneumonia, meningitis, and death. According to 
research by Han et al., molecular techniques not only 
identify a wide range of amniotic fluid infections but 
are also an appropriate method for the diagnosis of 
mixed infections [39]. 
A combination of PCR molecular method and 
culture methods has been proposed by Stakenborg in 
2005 for the identification of a wide range of 
Mycoplasma infections [40]. Also, PCR has previously 
been used to detect other infections such as falciparum 
and some viruses in cord blood [41]. The culture 
method which has been used to diagnose 
Mycoplasmasis very time consuming (1 to 4 weeks), 
has high false-negative results, and low sensitivity and 
specificity [42, 43].  
Based on the results, 715 bp DNA fragments 
were generated for Mycoplasma spp as a result of 
using GPO-3 and GMSO primers. The result is 
consistent with the results of Tabatabai Qomi and 
colleagues research [44]. 
The results of LOD using Mycoplasma culture 
dilution showed that PCR is a sensitive method for the 
detection of Mycoplasma spp and M. genitalium (100 
and 1000 copies in one test, respectively) (Figure 2). 
These results are consistent with the results of the 
study in which PCR was used to detect genital 
Mycoplasmas. A study by Kathleen et al., Proves that 
PCR is a rapid and sensitive method for the detection 
of this type of infection, but is also superior in 
comparison to the culture method [45]. However, as it 
has been demonstrated in some studies, the modified 
culture method is also highly sensitive for the 
detection of some species, such as M. hominis in 
patients’ endocervix[46].  
In the study by Najar Pirayeh et al. in 2007, the 
sensitivity of the PCR method and culture method was 
91.8% and 53%, respectively, indicating high 
sensitivity and rapidity of PCR in comparison to the 
culture method for the identification of these bacteria 
[47] .N-Luki et al. In Canada, performed a study by 
using PCR and culture techniques, to isolate U. 
urealyticum, M. hominis, and M. genitalium in clinical 
specimens obtained from 47 high-risk pregnant 
women and 8 newborns. PCR was used to isolate 
Ureaplasma in 31 out of 55 patients and facilitated M. 
hominis in 7 samples and M. genitalium in 2 samples. 
Four PCR-positive patients showed negative culture 
results [48]. 
Also, our results showed that the primers used 
did not produce any unwanted products with the DNA 
of other non-Mycoplasma bacteria such as M. 
tuberculosis, P. aeruginosa, S.typhimurium, S. aureus, 
and viruses such as B hepatitis and human DNA 
(Figure 3a). This suggests that the use of these primers 
in PCR provides high specificity for the detection of 
Mycoplasma species. It should be noted that PCR has 
been used for the detection of species such as M. 
tuberculosis [49], P. aeruginosa [50], S. typhimurium 
[51], S. aureus [52] and viruses such as B hepatitis 
[53]. Although the primers used were different and 
none of them studied samples were cord blood. 
             In another part of the study, PCR specificity 
for differential detection of M. genitalium was 
investigated using RMGe427 and FMGe427 primers. 
The results showed that no unwanted DNA products of 
bacteria such as M. pneumoniae, A. laidlawii, M. 
orale, M. arginini, M. hyorhinis, M. hominis and T. 
vaginalis were produced (Fig. 3b). This indicates that 
these primers are specific for M. genitalium and that 
PCR can also be used as a reliable method for 
differential diagnosis of this species. Because 
M.genitalium culture is time consuming, studies have 
shown that PCR is faster and more susceptible in 
comparison to cultivation [54, 55].For example, using 
a primer belonging to the gene encoding a binding 
protein, this species was identified in specimens 
collected from the throats of patients. On the other 
hand, other studies have identified the genome of M. 
genitalium in different genotypes by relying on the 
16S rRNA coding gene and PCR method. However, it 
has been proven that the use of primers with genes 
such as MgPa has the risk of inappropriate primer 
placement and misdiagnosis of M. genitalium. 
However, the LOD of the PCR test has been reported 
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to be approximately 1000 copies, which is consistent 
with the results of the present study [56]. However, all 
of this research has been done on tissues other than 
cord blood. It is noteworthy that M. genitalium 
contamination was not confirmed in any of the 
collected cord specimens. M.genitalium isolation rates, 
range from zero percent in the UK [57]to 34.4 percent 
in New Zealand[58]. Various studies have reported 
different prevalence of M. genitalium. This may be 
due to the type of study, the population studied 
(antibiotic use, genital infection, multiple sex partners, 
etc.) sample number, sampling method, age of 
patients, race, culture, geographic location, laboratory 
method (s) (Culture and PCR). 
Conclusion 
           Due to the potential impact of Mycoplasmas on 
the infection of pregnant mothers and neonatal 
transmission through the umbilical cord and important 
fetal outcomes, the need for timely diagnosis and 
treatment of these infectious agents is increasingly felt. 
Molecular methods such as PCR can provide a good 
prognosis for the rapid identification of important 
factors in congenital infections such as Mycoplasmas. 
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